Development of AML with t(8;21)(q22;q22) and RUNX1-RUNX1T1 fusion following Philadelphia-negative clonal evolution during treatment of CML with Imatinib.

Cancer Genet Cytogenet 2009 Feb;189(1):63-7

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cancergencyto.2008.09.016DOI Listing
February 2009

Publication Analysis

Top Keywords

clonal evolution
4
philadelphia-negative clonal
4
evolution treatment
4
treatment cml
4
cml imatinib
4
runx1-runx1t1 fusion
4
fusion philadelphia-negative
4
aml t821q22q22
4
development aml
4
t821q22q22 runx1-runx1t1
4
cml
1
t821q22q22
1
imatinib
1
treatment
1
runx1-runx1t1
1
philadelphia-negative
1
development
1
clonal
1
evolution
1
fusion
1

Similar Publications